Stay updated with breaking news from Retrocyte Display. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $40.00 price target on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the stock. StockNews.com began coverage on shares of […]
Although biotech stocks can present volatility risks due to its feast-or-famine nature, their narrative offers permanent relevance.
HC Wainwright reiterated their buy rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $40.00 price objective on the biotechnology company’s stock. AGEN has been the subject of a number of other reports. B. Riley reduced their price objective on […]
Research analysts at StockNews.com started coverage on shares of Agenus (NASDAQ:AGEN – Get Free Report) in a note issued to investors on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock. Several other brokerages also recently commented on AGEN. B. Riley dropped their target price on shares of Agenus from $120.00 to […]
StockNews.com upgraded shares of Agenus (NASDAQ:AGEN – Free Report) from a sell rating to a hold rating in a report issued on Sunday morning. AGEN has been the topic of several other research reports. HC Wainwright restated a buy rating and set a $8.00 target price on shares of Agenus in a report on Thursday, […]